©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 108892
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108892
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.108892
Figure 1 F4 promoted the maturation of bone marrow-derived dendritic cells in vitro.
A: Cytotoxicity of F4 on the proliferation of mouse colon CT26 cells; B: The purity (representative data) of bone marrow-derived dendritic cells (BMDCs) identified by flow cytometry; C: Cytotoxicity of F4 on the proliferation of BMDCs; D: Effects of F4 on the morphological change of BMDCs; E: Effects of F4 on the expressions of DC surface biomarkers cluster of differentiation (CD) 83 and CD86; F: Effects of F4 on the release of cytokines in the culture mediums. All data were shown as mean ± SD (n = 5). aP < 0.05. 1P vs control group. 2P vs lipopolysaccharides group. Ctrl: Control; 5-FU: 5-fluorouracil; CD: Cluster of differentiation; SSC-H: Side scatter high; BMDCs: Bone marrow-derived dendritic cells; LPS: Lipopolysaccharides; IL: Interleukin.
- Citation: Xie W, Li XJ, Zhong YS, Fang J, Qi H, Yang M, Ying HZ, Yu CH. Ginsenoside F4 inhibits colorectal cancer progression by boosting dendritic cell maturation and remodeling the tumor microenvironment. World J Gastrointest Oncol 2025; 17(9): 108892
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/108892.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.108892